Clinical Trials in Épagny, France
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Not Applicable
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Metastatic Triple-Negative Breast Carcinoma
UNICANCER472 enrolled51 locationsNCT06505018
Recruiting
Phase 2
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
NSCLC
Groupe Francais De Pneumo-Cancerologie45 enrolled27 locationsNCT06620835
Recruiting
Phase 2
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Large Cell Neuroendocrine Carcinoma of the Lung
Centre Leon Berard80 enrolled31 locationsNCT06393816